Latest Lead News

Jameson Resources has marked significant progress in advancing its Crown Mountain steelmaking coal project, doubling its pre-tax NPV to US$942 million and moving closer to final environmental approvals and development permits expected by the end of 2026.

RLF AgTech has secured strategic distribution partnerships with two leading Indian agricultural groups, marking its commercial entry into one of the world’s largest crop nutrition markets. These agreements position RLF for rapid expansion in India’s vast and growing agricultural sector.

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

Swift TV has secured its first contract to supply hardware and engineering services for a Walk to Work vessel linked to a major offshore Oil and Gas operator, marking a strategic entry into a key sector.

MGX Resources reported a $20.8 million half-year loss, driven by a major rockfall at Koolan Island that halted mining and triggered a $60 million asset impairment. The company is pivoting towards gold with its recent acquisition of a 50% stake in the Central Tanami Project.

Wesfarmers has reported a 9.3% rise in net profit after tax to $1.6 billion for H1 2026, driven by robust performances in Bunnings, Kmart Group, and lithium operations. The company also announced a 7.4% increase in its interim dividend amid ongoing cost pressures and strategic AI partnerships.

Transurban Group posted robust half-year results for December 2025, with revenue climbing 8.1% and profit rebounding to $343 million. The company also declared a 34-cent interim distribution, underpinned by strong cash flow and key project milestones.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.

Sports Entertainment Group reports a robust first half FY26 with nearly doubling EBITDA and declares special dividends following asset sales.

Servcorp has reported a robust first half for FY2026, with underlying profit soaring 34% and a strong dividend declared, signalling sustained momentum despite economic uncertainties.